Company Filing History:
Years Active: 2011-2013
Title: Katherine Sacksteder: Innovator in Infectious Disease Detection
Introduction
Katherine Sacksteder is a prominent inventor based in Baltimore, MD, known for her significant contributions to the field of infectious disease detection. With a total of two patents to her name, she has developed innovative methods that enhance the detection and understanding of infectious agents.
Latest Patents
Katherine's latest patents focus on methods and compositions for determining the pathogenic status of infectious agents. The first patent relates to improved detection techniques for infectious agents and microbes. This invention provides novel methods for detecting these agents, offering insights into their viability status and drug susceptibility. It employs nucleic acid amplification-based microbial identification alongside phage-based biological detection of drug resistance. The second patent also addresses the detection of diseases caused by infectious agents, utilizing unique combinations of nucleic acid amplification and drug susceptibility technologies. This invention is particularly useful for detecting mycobacterial infections, including tuberculosis.
Career Highlights
Katherine Sacksteder is currently associated with Sequella, Inc., where she continues to advance her research and innovations in the field of infectious diseases. Her work has been instrumental in developing technologies that improve the detection and treatment of various infections.
Collaborations
Katherine has collaborated with notable colleagues, including Matthew C Mulvey and Leo Einck, contributing to the advancement of her research and the development of her patents.
Conclusion
Katherine Sacksteder's innovative work in the detection of infectious agents showcases her commitment to improving public health through science and technology. Her contributions are vital in the ongoing battle against infectious diseases.